APA (7th ed.) Citation

Poon, V., Sutaria, D., Prell, R., Halpern, W., Wong, L., Harris, A., . . . Sane, R. (2025). Quantifying Risk of Delayed QT Prolongation of Ipatasertib in Preclinical and Clinical Studies in Cancer Patients. CTS: Clinical & Translational Science, 18(7), 1. https://doi.org/10.1111/cts.70298

Chicago Style (17th ed.) Citation

Poon, Victor, Dhruvitkumar Sutaria, Rodney Prell, Wendy Halpern, Lisa Wong, Adam Harris, Justin Wilkins, Kenta Yoshida, and Rucha Sane. "Quantifying Risk of Delayed QT Prolongation of Ipatasertib in Preclinical and Clinical Studies in Cancer Patients." CTS: Clinical & Translational Science 18, no. 7 (2025): 1. https://doi.org/10.1111/cts.70298.

MLA (9th ed.) Citation

Poon, Victor, et al. "Quantifying Risk of Delayed QT Prolongation of Ipatasertib in Preclinical and Clinical Studies in Cancer Patients." CTS: Clinical & Translational Science, vol. 18, no. 7, 2025, p. 1, https://doi.org/10.1111/cts.70298.